MIB1 and neoplasm: Despite several studies reporting a strong association between increased MIB-1 labeling indices and tumor recurrence or survival [58,60], there are also series that failed to demonstrate the MIB-1 labeling index as an independent marker for risk stratification in WHO grade 3 meningiomas [61,62].